---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-134571"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T00:21:42.233525+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Globus Medical, NuVasive get FTC second request for merger; Q3 2023 close expected

## Summary
- FTC issued Second Request on May 3, 2023, extending HSR waiting period for the merger.
- Both companies received requisite stockholder approvals at April 27, 2023 meetings.
- Merger expected to close in Q3 2023, subject to HSR clearance and other conditions.
- Globus and NuVasive are cooperating with FTC to satisfy the Second Request.

## SEC filing metadata
- accession: 0001193125-23-134571
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/0001193125-23-134571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/d352462d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-134571
- JSON: https://secwatch.observer/filing/0001193125-23-134571.json
- Plain text: https://secwatch.observer/filing/0001193125-23-134571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.